Scholars Central

Case reportPublished 19 Feb 2023

Long-term response after early discontinuation due to immunotherapy toxicity in metastatic renal cancer: a clinical case and literature review

Authors: Alessandro Rametta, Valentina Guadalupi, Elena Verzoni, Giuseppe Procopio

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Immunotherapy has a cardinal role in renal cancer, both in adjuvant setting and metastatic disease (first or subsequent lines). Severe Immune-Related Adverse Events (irAEs) occur in 10%-27% of patients treated with immunotherapy, but the discontinuation of the treatment due to toxicity doesn’t necessarily correlate with poor outcome. We present the case of a woman affected by metastatic clear cell renal cell carcinoma who presented a long-term response to second line treatment with Nivolumab after early interruption due to immuno-toxicity (hepatotoxicity, skin rash, hypothyroidism).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Oncology: Case Reports
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Alessandro Rametta”
  • BylineArticles whose byline prints “Valentina Guadalupi”
  • BylineArticles whose byline prints “Elena Verzoni”
  • BylineArticles whose byline prints “Giuseppe Procopio”